|
140
|
695
|
3ijeB |
Crystal structure of the complete integrin alhavbeta3 ectodomain plus an alpha/beta transmembrane fragment |
|
12
|
54
|
3iitB |
Factor xa in complex with a cis-1,2-diaminocyclohexane derivative |
|
199
|
551
|
3hs7A |
X-ray crystal structure of docosahexaenoic acid bound to the cyclooxygenase channel of cyclooxygenase-2 |
|
95
|
457
|
3ho5A |
Crystal structure of hedgehog-interacting protein (hhip) and sonic hedgehog (shh) complex |
|
87
|
456
|
3ho4A |
Crystal structure of hedgehog-interacting protein (hhip) |
|
203
|
551
|
3hs6A |
X-ray crystal structure of eicosapentaenoic acid bound to the cyclooxygenase channel of cyclooxygenase-2 |
|
79
|
456
|
3ho3A |
Crystal structure of hedgehog-interacting protein (hhip) |
|
17
|
89
|
3hptA |
Crystal structure of human fxa in complex with (s)-2-cyano-1-(2-methylbenzofuran-5-yl)-3-(2-oxo-1-(2-oxo-2-(pyrrolidin-1-yl)ethyl)azepan-3-yl)guanidine |
|
200
|
552
|
3hs5A |
X-ray crystal structure of arachidonic acid bound to the cyclooxygenase channel of cyclooxygenase-2 |
|
55
|
312
|
3h5cB |
X-ray structure of protein z-protein z inhibitor complex |
|
7
|
41
|
3gcxE |
Pcsk9:egfa (ph 7.4) |
|
6
|
41
|
3gcwE |
Pcsk9:egfa(h306y) |
|
15
|
115
|
3gisX |
Crystal structure of na-free thrombin in complex with thrombomodulin |
|
15
|
98
|
3f6uL |
Crystal structure of human activated protein c (apc) complexed with ppack |
|
149
|
535
|
3fbyA |
The crystal structure of the signature domain of cartilage oligomeric matrix protein. |
|
147
|
690
|
3fcsB |
Structure of complete ectodomain of integrin aiibb3 |
|
13
|
52
|
3ffgL |
Factor xa in complex with the inhibitor (r)-6-(2'-((3- hydroxypyrrolidin-1-yl)methyl)biphenyl-4-yl)-1-(3-(5-oxo-4,5-dihydro-1h-1,2,4-triazol-3-yl)phenyl)-3-(trifluoromethyl)-5,6-dihydro-1h-pyrazolo[3,4-c]pyridin- 7(4h)-one |
|
66
|
275
|
3f1sB |
Crystal structure of protein z complexed with protein z-dependent inhibitor |
|
19
|
89
|
3ensA |
Crystal structure of human fxa in complex with methyl (2z)-3-[(3-chloro-1h-indol-7-yl)amino]-2-cyano-3-{[(3s)-2-oxo-1-(2-oxo-2-pyrrolidin-1-ylethyl)azepan-3-yl]amino}acrylate |
|
18
|
95
|
3elaL |
Crystal structure of active site inhibited coagulation factor viia mutant in complex with soluble tissue factor |
|
6
|
53
|
3egfA |
Solution structure of murine epidermal growth factor determined by nmr spectroscopy and refined by energy minimization with restraints |
|
47
|
272
|
3demA |
Cub1-egf-cub2 domain of human masp-1/3 |
|
13
|
52
|
3cs7L |
Factor xa in complex with the inhibitor 1-(4-methoxyphenyl)-6-(4-(1-(pyrrolidin-1-ylmethyl)cyclopropyl)phenyl)-3-(trifluoromethyl)-5,6-dihydro-1h-pyrazolo[3,4-c]pyridin-7(4h)-one |
|
8
|
50
|
3ca7A |
High resolution crystal structure of the egf domain of spitz |
|
9
|
48
|
3c9aC |
High resolution crystal structure of argos bound to the egf domain of spitz |
|
35
|
156
|
3cfwA |
L-selectin lectin and egf domains |
|
13
|
52
|
3cenL |
Factor xa in complex with the inhibitor n-(2-(((5-chloro-2-pyridinyl) amino)sulfonyl)phenyl)-4-(2-oxo-1(2h)-pyridinyl)benzamide |
|
7
|
41
|
3bpsE |
Pcsk9:egf-a complex |
|
25
|
124
|
3bt2A |
Structure of urokinase receptor, urokinase and vitronectin complex |
|
20
|
125
|
3bt1A |
Structure of urokinase receptor, urokinase and vitronectin complex |
|
92
|
395
|
3asiA |
Alpha-neurexin-1 ectodomain fragment; lns5-egf3-lns6 |
|
30
|
180
|
2ygpA |
Wif domain-egf-like domain 1 met77trp of human wnt inhibitory factor 1 in complex with 1,2-dipalmitoylphosphatidylcholine |
|
33
|
241
|
2ygqA |
Wif domain-epidermal growth factor (egf)-like domains 1-3 of human wnt inhibitory factor 1 in complex with 1,2- dipalmitoylphosphatidylcholine |
|
31
|
180
|
2ygoA |
Wif domain-egf-like domain 1 of human wnt inhibitory factor 1 in complex with 1,2-dipalmitoylphosphatidylcholine |
|
12
|
52
|
2y7xB |
The discovery of potent and long-acting oral factor xa inhibitors with tetrahydroisoquinoline and benzazepine p4 motifs |
|
13
|
52
|
2y82B |
Structure and property based design of factor xa inhibitors: pyrrolidin-2-ones with aminoindane and phenylpyrrolidine p4 motifs |
|
12
|
54
|
2y5fL |
Factor xa - cation inhibitor complex |
|
12
|
54
|
2y5gL |
Factor xa - cation inhibitor complex |
|
12
|
52
|
2y7zB |
Structure and property based design of factor xa inhibitors: pyrrolidin-2-ones with aminoindane and phenylpyrrolidine p4 motifs |
|
12
|
54
|
2y5hL |
Factor xa - cation inhibitor complex |
|
12
|
52
|
2y80B |
Structure and property based design of factor xa inhibitors: pyrrolidin-2-ones with aminoindane and phenylpyrrolidine p4 motifs |
|
64
|
391
|
2y38A |
Laminin alpha5 chain n-terminal fragment |
|
12
|
52
|
2y81B |
Structure and property based design of factor xa inhibitors: pyrrolidin-2-ones with aminoindane and phenylpyrrolidine p4 motifs |
|
9
|
50
|
2xc0L |
Factor xa in complex with a pyrrolidine-3,4-dicarboxylic acid inhibitor |
|
10
|
50
|
2xbwL |
Factor xa in complex with a pyrrolidine-3,4-dicarboxylic acid inhibitor |
|
9
|
50
|
2xbxL |
Factor xa in complex with a pyrrolidine-3,4-dicarboxylic acid inhibitor |
|
6
|
50
|
2xbyL |
Factor xa in complex with a pyrrolidine-3,4-dicarboxylic acid inhibitor |
|
10
|
50
|
2xc5L |
Factor xa in complex with a pyrrolidine-3,4-dicarboxylic acid inhibitor |
|
11
|
54
|
2xc4L |
Factor xa in complex with a pyrrolidine-3,4-dicarboxylic acid inhibitor |
|
7
|
50
|
2xbvL |
Factor xa in complex with a pyrrolidine-3,4-dicarboxylic acid inhibitor |
